AN2 Therapeutics Inc

NASDAQ ANTX

Data sourced from iex and EODHD
Download Data

AN2 Therapeutics Inc Income Statement 2021 - 2024

This table shows the Income Statement for AN2 Therapeutics Inc going from 2021 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue
M 0 0 0 - - - - - - - - - -
Gross Profit
M 0 0 0 - - - - - - - - - -
Operating Expenses
M 35 33 45 - - - - - - - - - -
Selling, General, and Administrative Expenses (SG&A)
M 14 15 15 14 15 13 11 9 6 5 3 1 0
Research and Development (R&D) Expenses
M 58 55 49 43 36 30 27 23 21 17 11 6 2
Other Operating Expenses
M 0 0 0 - - - - - - - - - -
Costs and Expenses
M 35 33 45 - - - - - - - - - -
Operating Income
M -72 -70 -63 -57 -51 -42 -37 -32 -27 -22 -14 -7 -2
Interest Expense
M 1 -1 0 1 1 2 1 0 0 0 0 0 0
Non-operating Income/Expense
M 6 5 4 3 2 1 1 0 0 0 0 0 0
EBT
M -66 -65 -60 -54 -49 -41 -37 -32 -27 -22 -14 -7 -2
Income Tax Provision
M -18 -1 0 0 -1 0 -1 0 0 - - - -
Income after Tax
M -48 -64 -60 -38 -48 -41 -28 -17 -8 - - - -
Non-Controlling Interest
M 0 0 0 0 0 2 2 4 6 5 5 3 1
Net Income
M -16 -31 -43 -54 -49 -43 -31 -28 -25 -19 -19 -10 -3
Shares (Basic, Weighted)
M - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 26,160,397.50 23,565,989.50 20,970,353.75 19,395,785.50 19,335,928.50 15,284,696.25 14,981,429.25 13,656,563.25 12,353,967.75 15,070,709.50 14,047,684.00 14,047,684.00 14,047,684.00
EBITDA
M -72 -70 -63 -57 -51 -42 -37 -33 -27 -22 -14 -7 -2
Depreciation and Amortization
M 18 0 -1 0 0 0 1 0 0 - - - -
EBIT
M -90 -70 -62 -54 -49 -41 -30 -25 -20 -14 -14 -7 -2
Income from Discontinued Operations
M - - - - - - - - - - - - -
Tax Rate (Effective)
% 27.61 1.26 -0.77 0.16 1.21 0.22 2.96 2.54 0.72 - - - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit Margin
% 50.00 - - - - - - - - - - - -
Operating Income Margin
% -23,518.75 - - - - - - - - - - - -
Net Income Margin
% - - - - - - - - - - - - -
EBITDA Ratio
% -23,518.75 - - - - - - - - - - - -
EBIT Ratio
% -23,542.27 - - - - - - - - - - - -
EBT Ratio
% -21,122.50 - - - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email